Nitta Gelatin India Limited
BSE: NITTAGELA · Specialty Chemicals
Snapshot
Unlock Nitta Gelatin India Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Nitta Gelatin India Ltd. is a specialty chemicals company primarily engaged in the manufacture and distribution of gelatin, ossein, and collagen peptides. Its product portfolio serves diverse sectors including pharmaceuticals, food, and nutrition.
Business Model
The company generates revenue through the large-scale production and sale of gelatin-based products and derivatives like di-calcium phosphate and chitosan. It leverages its technical expertise to supply high-quality ingredients to the pharmaceutical and food processing industries.
Growth Outlook
Growth is driven by the increasing demand for collagen peptides in the health and wellness segment and the expansion of pharmaceutical applications for gelatin. The company continues to focus on operational efficiencies and product innovation to maintain its market position.
Key Risks
- Raw Material Price Volatility. Fluctuations in the cost of ossein and other raw materials can significantly impact profit margins.
- Regulatory Compliance. The company must adhere to stringent international quality and safety standards for pharmaceutical and food-grade products.
- Environmental Regulations. As a chemical manufacturer, the company faces risks related to evolving environmental norms and waste management requirements.
- Currency Risk. Exposure to foreign exchange fluctuations may affect the profitability of export-oriented product lines.
Start your research today
Unlock AI insights, financials, peers and live data on Nitta Gelatin India Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹590 Cr
TTM · consolidated
NET PROFIT
₹103 Cr
TTM · consolidated
EPS
₹113.74
TTM · consolidated
RETURN ON EQUITY
22.1%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
29.4%
TTM · consolidated
P/E
15.4×
Q1 FY27 · consolidated
EV/EBITDA
10.1x
Q1 FY27 · consolidated
EBITDA MARGIN
26.6%
TTM · consolidated
NET PROFIT MARGIN
17.9%
Q1 FY27 · consolidated
DEBT TO EQUITY
0.0x
Q1 FY27 · consolidated
Peers · Specialty Chemicals
| Company | Mkt Cap | P/E (TTM) | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Nitta Gelatin India LimitedNITTAGELA | ₹1,591 Cr | 15.4× | 10.05 | 10.0% | 26.6% | 22.1% | 29.4% | +95.4% |
IndokemINDOKEM | ₹1,756 Cr | 777.2× | 211.61 | -4.5% | 4.8% | 3.5% | 6.7% | -9.1% |
Camlin Fine Sciences LimitedCAMLINFINE | ₹1,699 Cr | 327.7× | 19.03 | 8.4% | 6.4% | 0.1% | 0.5% | -54.8% |
Titan BiotechTITANBIO | ₹1,682 Cr | 13.6× | 34.46 | 36.9% | 22.3% | 20.2% | 25.3% | -69.1% |
Vidhi Specialty Food Ingredients LimitedVIDHIING | ₹1,535 Cr | 25.5× | 16.92 | 34.8% | 18.7% | 17.9% | 24.5% | -9.1% |
PaushakPAUSHAKLTD | ₹1,495 Cr | 31.6× | 16.50 | 28.0% | 34.1% | 9.5% | 10.9% | -17.7% |
As of Q1 FY27
Financials
Nitta Gelatin India Limited
BSE: NITTAGELA · Specialty Chemicals
Snapshot
Unlock Nitta Gelatin India Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Nitta Gelatin India Ltd. is a specialty chemicals company primarily engaged in the manufacture and distribution of gelatin, ossein, and collagen peptides. Its product portfolio serves diverse sectors including pharmaceuticals, food, and nutrition.
Business Model
The company generates revenue through the large-scale production and sale of gelatin-based products and derivatives like di-calcium phosphate and chitosan. It leverages its technical expertise to supply high-quality ingredients to the pharmaceutical and food processing industries.
Growth Outlook
Growth is driven by the increasing demand for collagen peptides in the health and wellness segment and the expansion of pharmaceutical applications for gelatin. The company continues to focus on operational efficiencies and product innovation to maintain its market position.
Key Risks
- Raw Material Price Volatility. Fluctuations in the cost of ossein and other raw materials can significantly impact profit margins.
- Regulatory Compliance. The company must adhere to stringent international quality and safety standards for pharmaceutical and food-grade products.
- Environmental Regulations. As a chemical manufacturer, the company faces risks related to evolving environmental norms and waste management requirements.
- Currency Risk. Exposure to foreign exchange fluctuations may affect the profitability of export-oriented product lines.
Start your research today
Unlock AI insights, financials, peers and live data on Nitta Gelatin India Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹590 Cr
TTM · consolidated
NET PROFIT
₹103 Cr
TTM · consolidated
EPS
₹113.74
TTM · consolidated
RETURN ON EQUITY
22.1%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
29.4%
TTM · consolidated
P/E
15.4x
Q1 FY27 · consolidated
EV/EBITDA
10.1x
Q1 FY27 · consolidated
EBITDA MARGIN
26.6%
TTM · consolidated
NET PROFIT MARGIN
17.9%
Q1 FY27 · consolidated
DEBT TO EQUITY
0.0x
Q1 FY27 · consolidated
Peers · Specialty Chemicals
As of Q1 FY27